SCHEMBL17847437

SCHEMBL17847437

NP(=O)(O)Oc1cccc([N+](=O)[O-])c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.43
GPR35 Q9HC97 2/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
TDP1 Q9NUW8 6/20 0.40
NPC1 O15118 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
GRM8 O00222 1/20 0.38
GRM4 Q14833 1/20 0.38
MEN1 O00255 1/20 0.38
TTR P02766 1/20 0.38
ALB P02768 1/20 0.38
THRB P10828 1/20 0.38
KMT2A Q03164 1/20 0.38
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
CTSD P07339 1/20 0.36
HSPB1 P04792 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17847436 0.88 SMN1; SMN2 (0.50) HPGDGPR35ALDH1A1KDM4ETDP1
SCHEMBL2438825 0.84 HPGD (0.47) HPGDGPR35ALDH1A1KDM4ETDP1
SCHEMBL30106402 0.84 ALDH1A1 (0.53) HPGDGPR35ALDH1A1KDM4ETDP1
SCHEMBL11497260 0.77 HPGD (0.62) HPGDGPR35ALDH1A1TDP1NPC1
SCHEMBL28931147 0.75 HPGD (0.45) HPGDGPR35ALDH1A1KDM4ETDP1
SCHEMBL2496089 0.74 TDP1 (0.67) HPGDALDH1A1KDM4ETDP1NPC1
SCHEMBL28637817 0.73 TDP1 (0.50) HPGDGPR35TDP1MEN1TTR
SCHEMBL10499773 0.72 ALDH1A1 (0.46) HPGDGPR35ALDH1A1KDM4ETDP1
SCHEMBL28938591 0.72 PHGDH (0.42) GPR35ALDH1A1TDP1NPC1RAB9A
SCHEMBL14372522 0.72 HPGD (0.45) HPGDGPR35ALDH1A1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3474863-A1 PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS Emory University (US) 2019-05-01 EP disclosed
WO-2017223421-A1 PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS EMORY UNIVERSITY (US) 2017-12-28 WO disclosed
EP-3233878-A2 PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS Emory University (US) 2017-10-25 EP disclosed
WO-2016099982-A2 PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS EMORY UNIVERSITY (US) 2016-06-23 WO disclosed